ID   SAHH_HUMAN              Reviewed;         432 AA.
AC   P23526; A8K307; B3KUN3; E1P5P2; F5H737; Q96A36;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 189.
DE   RecName: Full=Adenosylhomocysteinase;
DE            Short=AdoHcyase;
DE            EC=3.3.1.1;
DE   AltName: Full=S-adenosyl-L-homocysteine hydrolase;
GN   Name=AHCY; Synonyms=SAHH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASN-86.
RC   TISSUE=Placenta;
RX   PubMed=2596825; DOI=10.1111/j.1469-1809.1989.tb01781.x;
RA   Coulter-Karis D.E., Hershfield M.S.;
RT   "Sequence of full length cDNA for human S-adenosylhomocysteine
RT   hydrolase.";
RL   Ann. Hum. Genet. 53:169-175(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-6; 104-108 AND 198-202.
RX   PubMed=7786017; DOI=10.1006/abbi.1995.1306;
RA   Gupta R.A., Yuan C.-S., Ault-Riche D.B., Borchardt R.T.;
RT   "Limited proteolysis of S-adenosylhomocysteine hydrolase: implications
RT   for the three-dimensional structure.";
RL   Arch. Biochem. Biophys. 319:365-371(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-34; 95-103; 143-186; 215-226; 336-343 AND
RP   389-405, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 122-432 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2574561; DOI=10.1111/j.1469-1809.1989.tb01780.x;
RA   Arredondo-Vega F.X., Charlton J.A., Edwards Y.H., Hopkinson D.A.,
RA   Whitehouse D.B.;
RT   "Isozyme and DNA analysis of human S-adenosyl-L-homocysteine hydrolase
RT   (AHCY).";
RL   Ann. Hum. Genet. 53:157-167(1989).
RN   [10]
RP   PROTEIN SEQUENCE OF 175-186 AND 319-327.
RX   PubMed=7608178; DOI=10.1074/jbc.270.27.16140;
RA   Yuan C.S., Borchardt R.T.;
RT   "Photoaffinity labeling of human placental S-adenosylhomocysteine
RT   hydrolase with [2-3H]8-azido-adenosine.";
RL   J. Biol. Chem. 270:16140-16146(1995).
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH NAD AND
RP   ADENOSINE ANALOG, SUBUNIT, AND COFACTOR.
RC   TISSUE=Placenta;
RX   PubMed=9586999; DOI=10.1038/nsb0598-369;
RA   Turner M.A., Yuan C.S., Borchardt R.T., Hershfield M.S., Smith G.D.,
RA   Howell P.L.;
RT   "Structure determination of selenomethionyl S-adenosylhomocysteine
RT   hydrolase using data at a single wavelength.";
RL   Nat. Struct. Biol. 5:369-376(1998).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) IN COMPLEX WITH NAD AND
RP   NEPLANOCIN A, FUNCTION, AND COFACTOR.
RX   PubMed=12590576; DOI=10.1021/bi0262350;
RA   Yang X., Hu Y., Yin D.H., Turner M.A., Wang M., Borchardt R.T.,
RA   Howell P.L., Kuczera K., Schowen R.L.;
RT   "Catalytic strategy of S-adenosyl-L-homocysteine hydrolase:
RT   transition-state stabilization and the avoidance of abortive
RT   reactions.";
RL   Biochemistry 42:1900-1909(2003).
RN   [17]
RP   VARIANT TRP-38.
RX   PubMed=15241484; DOI=10.1038/sj.ejhg.5201237;
RA   Gellekink H., den Heijer M., Kluijtmans L.A., Blom H.J.;
RT   "Effect of genetic variation in the human S-adenosylhomocysteine
RT   hydrolase gene on total homocysteine concentrations and risk of
RT   recurrent venous thrombosis.";
RL   Eur. J. Hum. Genet. 12:942-948(2004).
RN   [18]
RP   VARIANT HMAHCHD CYS-143.
RX   PubMed=15024124; DOI=10.1073/pnas.0400658101;
RA   Baric I., Fumic K., Glenn B., Cuk M., Schulze A., Finkelstein J.D.,
RA   James S.J., Mejaski-Bosnjak V., Pazanin L., Pogribny I.P., Rados M.,
RA   Sarnavka V., Scukanec-Spoljar M., Allen R.H., Stabler S., Uzelac L.,
RA   Vugrek O., Wagner C., Zeisel S., Mudd S.H.;
RT   "S-adenosylhomocysteine hydrolase deficiency in a human: a genetic
RT   disorder of methionine metabolism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4234-4239(2004).
RN   [19]
RP   VARIANTS HMAHCHD VAL-89 AND CYS-143.
RX   PubMed=16736098; DOI=10.1007/s10545-006-0240-0;
RA   Buist N.R., Glenn B., Vugrek O., Wagner C., Stabler S., Allen R.H.,
RA   Pogribny I., Schulze A., Zeisel S.H., Baric I., Mudd S.H.;
RT   "S-adenosylhomocysteine hydrolase deficiency in a 26-year-old man.";
RL   J. Inherit. Metab. Dis. 29:538-545(2006).
RN   [20]
RP   VARIANTS HMAHCHD CYS-49 AND GLY-86.
RX   PubMed=19177456; DOI=10.1002/humu.20985;
RA   Vugrek O., Beluzic R., Nakic N., Mudd S.H.;
RT   "S-adenosylhomocysteine hydrolase (AHCY) deficiency: two novel
RT   mutations with lethal outcome.";
RL   Hum. Mutat. 30:E555-E565(2009).
RN   [21]
RP   VARIANTS HMAHCHD CYS-49 AND GLY-86.
RX   PubMed=20852937; DOI=10.1007/s10545-010-9171-x;
RA   Grubbs R., Vugrek O., Deisch J., Wagner C., Stabler S., Allen R.,
RA   Baric I., Rados M., Mudd S.H.;
RT   "S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal
RT   hydrops and fatal outcomes.";
RL   J. Inherit. Metab. Dis. 33:705-713(2010).
CC   -!- FUNCTION: Adenosylhomocysteine is a competitive inhibitor of S-
CC       adenosyl-L-methionine-dependent methyl transferase reactions;
CC       therefore adenosylhomocysteinase may play a key role in the
CC       control of methylations via regulation of the intracellular
CC       concentration of adenosylhomocysteine.
CC       {ECO:0000269|PubMed:12590576}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-homocysteine + H(2)O = L-
CC       homocysteine + adenosine.
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:12590576,
CC         ECO:0000269|PubMed:9586999};
CC       Note=Binds 1 NAD(+) per subunit. {ECO:0000269|PubMed:12590576,
CC       ECO:0000269|PubMed:9586999};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-homocysteine biosynthesis; L-
CC       homocysteine from S-adenosyl-L-homocysteine: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12590576,
CC       ECO:0000269|PubMed:9586999}.
CC   -!- INTERACTION:
CC       Q6AI12:ANKRD40; NbExp=6; IntAct=EBI-1053240, EBI-2838246;
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-1053240, EBI-743771;
CC       Q9BV19:C1orf50; NbExp=9; IntAct=EBI-1053240, EBI-2874661;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P23526-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23526-2; Sequence=VSP_045404;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Hypermethioninemia with S-adenosylhomocysteine hydrolase
CC       deficiency (HMAHCHD) [MIM:613752]: A metabolic disorder
CC       characterized by hypermethioninemia associated with failure to
CC       thrive, mental and motor retardation, facial dysmorphism with
CC       abnormal hair and teeth, and myocardiopathy.
CC       {ECO:0000269|PubMed:15024124, ECO:0000269|PubMed:16736098,
CC       ECO:0000269|PubMed:19177456, ECO:0000269|PubMed:20852937}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenosylhomocysteinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61831; AAA51681.1; -; mRNA.
DR   EMBL; M61832; AAA51682.1; -; mRNA.
DR   EMBL; BT006697; AAP35343.1; -; mRNA.
DR   EMBL; AK097610; BAG53495.1; -; mRNA.
DR   EMBL; AK290422; BAF83111.1; -; mRNA.
DR   EMBL; AL356299; CAC09528.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76279.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76280.1; -; Genomic_DNA.
DR   EMBL; BC010018; AAH10018.1; -; mRNA.
DR   EMBL; BC011606; AAH11606.1; -; mRNA.
DR   CCDS; CCDS13233.1; -. [P23526-1]
DR   CCDS; CCDS54457.1; -. [P23526-2]
DR   PIR; A43629; A43629.
DR   RefSeq; NP_000678.1; NM_000687.3. [P23526-1]
DR   RefSeq; NP_001155238.1; NM_001161766.1. [P23526-2]
DR   RefSeq; NP_001309013.1; NM_001322084.1. [P23526-2]
DR   RefSeq; NP_001309014.1; NM_001322085.1. [P23526-2]
DR   RefSeq; XP_005260374.1; XM_005260317.2. [P23526-2]
DR   RefSeq; XP_011526961.1; XM_011528659.1. [P23526-2]
DR   RefSeq; XP_016883197.1; XM_017027708.1. [P23526-1]
DR   RefSeq; XP_016883198.1; XM_017027709.1. [P23526-1]
DR   UniGene; Hs.388004; -.
DR   PDB; 1A7A; X-ray; 2.80 A; A/B=1-432.
DR   PDB; 1LI4; X-ray; 2.01 A; A=1-432.
DR   PDB; 3NJ4; X-ray; 2.50 A; A/B/C/D=1-432.
DR   PDB; 4PFJ; X-ray; 2.30 A; A/B=1-432.
DR   PDB; 4PGF; X-ray; 2.59 A; A/B=1-432.
DR   PDB; 4YVF; X-ray; 2.70 A; A/B=1-432.
DR   PDBsum; 1A7A; -.
DR   PDBsum; 1LI4; -.
DR   PDBsum; 3NJ4; -.
DR   PDBsum; 4PFJ; -.
DR   PDBsum; 4PGF; -.
DR   PDBsum; 4YVF; -.
DR   ProteinModelPortal; P23526; -.
DR   SMR; P23526; -.
DR   BioGrid; 106696; 73.
DR   IntAct; P23526; 25.
DR   MINT; MINT-5000523; -.
DR   STRING; 9606.ENSP00000217426; -.
DR   BindingDB; P23526; -.
DR   ChEMBL; CHEMBL2664; -.
DR   DrugBank; DB03273; 3'-Oxo-Adenosine.
DR   DrugBank; DB03769; D-Eritadenine.
DR   DrugBank; DB02325; Isopropyl Alcohol.
DR   GuidetoPHARMACOLOGY; 1233; -.
DR   iPTMnet; P23526; -.
DR   PhosphoSitePlus; P23526; -.
DR   SwissPalm; P23526; -.
DR   BioMuta; AHCY; -.
DR   DMDM; 20141702; -.
DR   REPRODUCTION-2DPAGE; IPI00012007; -.
DR   EPD; P23526; -.
DR   MaxQB; P23526; -.
DR   PaxDb; P23526; -.
DR   PeptideAtlas; P23526; -.
DR   PRIDE; P23526; -.
DR   DNASU; 191; -.
DR   Ensembl; ENST00000217426; ENSP00000217426; ENSG00000101444. [P23526-1]
DR   Ensembl; ENST00000538132; ENSP00000442820; ENSG00000101444. [P23526-2]
DR   GeneID; 191; -.
DR   KEGG; hsa:191; -.
DR   UCSC; uc002xai.4; human. [P23526-1]
DR   CTD; 191; -.
DR   DisGeNET; 191; -.
DR   GeneCards; AHCY; -.
DR   HGNC; HGNC:343; AHCY.
DR   HPA; HPA041225; -.
DR   HPA; HPA044675; -.
DR   MalaCards; AHCY; -.
DR   MIM; 180960; gene.
DR   MIM; 613752; phenotype.
DR   neXtProt; NX_P23526; -.
DR   OpenTargets; ENSG00000101444; -.
DR   Orphanet; 88618; Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency.
DR   PharmGKB; PA24636; -.
DR   eggNOG; KOG1370; Eukaryota.
DR   eggNOG; COG0499; LUCA.
DR   GeneTree; ENSGT00390000003626; -.
DR   HOGENOM; HOG000227987; -.
DR   HOVERGEN; HBG005041; -.
DR   InParanoid; P23526; -.
DR   KO; K01251; -.
DR   OMA; VHDKYPQ; -.
DR   OrthoDB; EOG091G06EB; -.
DR   PhylomeDB; P23526; -.
DR   TreeFam; TF300415; -.
DR   BRENDA; 3.3.1.1; 2681.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-HSA-2408508; Metabolism of ingested SeMet, Sec, MeSec into H2Se.
DR   SABIO-RK; P23526; -.
DR   UniPathway; UPA00314; UER00076.
DR   ChiTaRS; AHCY; human.
DR   EvolutionaryTrace; P23526; -.
DR   GenomeRNAi; 191; -.
DR   PRO; PR:P23526; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101444; -.
DR   CleanEx; HS_AHCY; -.
DR   Genevisible; P23526; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0004013; F:adenosylhomocysteinase activity; TAS:UniProtKB.
DR   GO; GO:0030554; F:adenyl nucleotide binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0002439; P:chronic inflammatory response to antigenic stimulus; IEA:Ensembl.
DR   GO; GO:0042745; P:circadian sleep/wake cycle; IEA:Ensembl.
DR   GO; GO:0071268; P:homocysteine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0019510; P:S-adenosylhomocysteine catabolic process; IEA:Ensembl.
DR   GO; GO:0033353; P:S-adenosylmethionine cycle; IBA:GO_Central.
DR   GO; GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome.
DR   CDD; cd00401; SAHH; 1.
DR   HAMAP; MF_00563; AdoHcyase; 1.
DR   InterPro; IPR034373; Adenosylhomocysteinase.
DR   InterPro; IPR000043; Adenosylhomocysteinase-like.
DR   InterPro; IPR015878; Ado_hCys_hydrolase_NAD-bd.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020082; S-Ado-L-homoCys_hydrolase_CS.
DR   PANTHER; PTHR23420; PTHR23420; 1.
DR   Pfam; PF05221; AdoHcyase; 1.
DR   Pfam; PF00670; AdoHcyase_NAD; 1.
DR   PIRSF; PIRSF001109; Ad_hcy_hydrolase; 1.
DR   SMART; SM00996; AdoHcyase; 1.
DR   SMART; SM00997; AdoHcyase_NAD; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00936; ahcY; 1.
DR   PROSITE; PS00738; ADOHCYASE_1; 1.
DR   PROSITE; PS00739; ADOHCYASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disease mutation; Hydrolase;
KW   NAD; One-carbon metabolism; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7786017,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    432       Adenosylhomocysteinase.
FT                                /FTId=PRO_0000116902.
FT   NP_BIND     157    159       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   NP_BIND     222    227       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   NP_BIND     299    301       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   BINDING      57     57       Substrate. {ECO:0000250}.
FT   BINDING     131    131       Substrate. {ECO:0000250}.
FT   BINDING     156    156       Substrate. {ECO:0000250}.
FT   BINDING     186    186       Substrate. {ECO:0000250}.
FT   BINDING     190    190       Substrate. {ECO:0000250}.
FT   BINDING     243    243       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   BINDING     248    248       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   BINDING     346    346       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   BINDING     353    353       NAD. {ECO:0000269|PubMed:12590576,
FT                                ECO:0000269|PubMed:9586999}.
FT   MOD_RES       2      2       N-acetylserine. {ECO:0000269|Ref.8}.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     193    193       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P50247}.
FT   VAR_SEQ       1     28       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045404.
FT   VARIANT      38     38       R -> W (in dbSNP:rs13043752).
FT                                {ECO:0000269|PubMed:15241484}.
FT                                /FTId=VAR_052286.
FT   VARIANT      49     49       R -> C (in HMAHCHD; dbSNP:rs369428934).
FT                                {ECO:0000269|PubMed:19177456,
FT                                ECO:0000269|PubMed:20852937}.
FT                                /FTId=VAR_058588.
FT   VARIANT      86     86       D -> G (in HMAHCHD; dbSNP:rs773162208).
FT                                {ECO:0000269|PubMed:19177456,
FT                                ECO:0000269|PubMed:20852937}.
FT                                /FTId=VAR_058589.
FT   VARIANT      86     86       D -> N. {ECO:0000269|PubMed:2596825}.
FT                                /FTId=VAR_006934.
FT   VARIANT      89     89       A -> V (in HMAHCHD; dbSNP:rs755222515).
FT                                {ECO:0000269|PubMed:16736098}.
FT                                /FTId=VAR_058590.
FT   VARIANT     143    143       Y -> C (in HMAHCHD; dbSNP:rs121918608).
FT                                {ECO:0000269|PubMed:15024124,
FT                                ECO:0000269|PubMed:16736098}.
FT                                /FTId=VAR_058591.
FT   CONFLICT    249    249       A -> V (in Ref. 3; BAG53495).
FT                                {ECO:0000305}.
FT   STRAND        8     10       {ECO:0000244|PDB:1LI4}.
FT   HELIX        12     14       {ECO:0000244|PDB:1LI4}.
FT   HELIX        15     26       {ECO:0000244|PDB:1LI4}.
FT   HELIX        30     39       {ECO:0000244|PDB:1LI4}.
FT   TURN         40     42       {ECO:0000244|PDB:1LI4}.
FT   TURN         44     47       {ECO:0000244|PDB:1LI4}.
FT   STRAND       49     54       {ECO:0000244|PDB:1LI4}.
FT   HELIX        58     69       {ECO:0000244|PDB:1LI4}.
FT   STRAND       73     77       {ECO:0000244|PDB:1LI4}.
FT   STRAND       79     82       {ECO:0000244|PDB:3NJ4}.
FT   HELIX        86     94       {ECO:0000244|PDB:1LI4}.
FT   STRAND       99    101       {ECO:0000244|PDB:1LI4}.
FT   HELIX       107    115       {ECO:0000244|PDB:1LI4}.
FT   STRAND      118    120       {ECO:0000244|PDB:1LI4}.
FT   STRAND      126    133       {ECO:0000244|PDB:1LI4}.
FT   HELIX       134    142       {ECO:0000244|PDB:1LI4}.
FT   HELIX       144    149       {ECO:0000244|PDB:1LI4}.
FT   STRAND      152    155       {ECO:0000244|PDB:1LI4}.
FT   HELIX       158    169       {ECO:0000244|PDB:1LI4}.
FT   STRAND      175    179       {ECO:0000244|PDB:1LI4}.
FT   HELIX       184    187       {ECO:0000244|PDB:1LI4}.
FT   HELIX       190    207       {ECO:0000244|PDB:1LI4}.
FT   STRAND      215    219       {ECO:0000244|PDB:1LI4}.
FT   HELIX       223    234       {ECO:0000244|PDB:1LI4}.
FT   STRAND      238    242       {ECO:0000244|PDB:1LI4}.
FT   HELIX       246    254       {ECO:0000244|PDB:1LI4}.
FT   HELIX       262    265       {ECO:0000244|PDB:1LI4}.
FT   TURN        266    268       {ECO:0000244|PDB:1LI4}.
FT   STRAND      270    274       {ECO:0000244|PDB:1LI4}.
FT   STRAND      277    279       {ECO:0000244|PDB:3NJ4}.
FT   HELIX       284    287       {ECO:0000244|PDB:1LI4}.
FT   STRAND      294    298       {ECO:0000244|PDB:1LI4}.
FT   STRAND      300    302       {ECO:0000244|PDB:1LI4}.
FT   HELIX       308    314       {ECO:0000244|PDB:1LI4}.
FT   STRAND      316    322       {ECO:0000244|PDB:1LI4}.
FT   STRAND      325    329       {ECO:0000244|PDB:1LI4}.
FT   STRAND      335    339       {ECO:0000244|PDB:1LI4}.
FT   HELIX       340    342       {ECO:0000244|PDB:1LI4}.
FT   HELIX       345    348       {ECO:0000244|PDB:1LI4}.
FT   HELIX       355    374       {ECO:0000244|PDB:1LI4}.
FT   HELIX       376    378       {ECO:0000244|PDB:1LI4}.
FT   STRAND      381    384       {ECO:0000244|PDB:1LI4}.
FT   HELIX       388    399       {ECO:0000244|PDB:1LI4}.
FT   TURN        400    403       {ECO:0000244|PDB:1LI4}.
FT   HELIX       411    417       {ECO:0000244|PDB:1LI4}.
FT   STRAND      421    423       {ECO:0000244|PDB:3NJ4}.
SQ   SEQUENCE   432 AA;  47716 MW;  2833C025F969553E CRC64;
     MSDKLPYKVA DIGLAAWGRK ALDIAENEMP GLMRMRERYS ASKPLKGARI AGCLHMTVET
     AVLIETLVTL GAEVQWSSCN IFSTQDHAAA AIAKAGIPVY AWKGETDEEY LWCIEQTLYF
     KDGPLNMILD DGGDLTNLIH TKYPQLLPGI RGISEETTTG VHNLYKMMAN GILKVPAINV
     NDSVTKSKFD NLYGCRESLI DGIKRATDVM IAGKVAVVAG YGDVGKGCAQ ALRGFGARVI
     ITEIDPINAL QAAMEGYEVT TMDEACQEGN IFVTTTGCID IILGRHFEQM KDDAIVCNIG
     HFDVEIDVKW LNENAVEKVN IKPQVDRYRL KNGRRIILLA EGRLVNLGCA MGHPSFVMSN
     SFTNQVMAQI ELWTHPDKYP VGVHFLPKKL DEAVAEAHLG KLNVKLTKLT EKQAQYLGMS
     CDGPFKPDHY RY
//
